Cargando…
Naringin Dihydrochalcone Ameliorates Cognitive Deficits and Neuropathology in APP/PS1 Transgenic Mice
Alzheimer’s disease (AD) is a multi-factorial neurodegenerative disorder with abnormal accumulation of amyloid-β (Aβ) plaques, neuroinflammation and impaired neurogenesis. Mounting evidences suggest that single-target drugs have limited effects on clinical treatment and alternative or multiple targe...
Autores principales: | Yang, Wenjuan, Zhou, Keyan, Zhou, Yue, An, Yuqian, Hu, Tingting, Lu, Jing, Huang, Shichao, Pei, Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996202/ https://www.ncbi.nlm.nih.gov/pubmed/29922152 http://dx.doi.org/10.3389/fnagi.2018.00169 |
Ejemplares similares
-
Zerumbone ameliorates behavioral impairments and neuropathology in transgenic APP/PS1 mice by suppressing MAPK signaling
por: Li, Lei, et al.
Publicado: (2020) -
Naringin ameliorates cognitive deficits in streptozotocin-induced diabetic rats
por: Liu, Xianchu, et al.
Publicado: (2016) -
Amelioration of Behavioral Impairments and Neuropathology by Antiepileptic Drug Topiramate in a Transgenic Alzheimer’s Disease Model Mice, APP/PS1
por: Owona, Brice Ayissi, et al.
Publicado: (2019) -
DL0410 ameliorates cognitive deficits in APP/PS1 transgenic mice by promoting synaptic transmission and reducing neuronal loss
por: Zhou, Wei, et al.
Publicado: (2019) -
Vaccine Development to Treat Alzheimer's Disease Neuropathology in APP/PS1 Transgenic Mice
por: Carrera, Iván, et al.
Publicado: (2012)